Dana-Farber Cancer Institute
450 Brookline AvenueBoston, MA 02215
I am interested in hematopoietic stem cell transplant for malignant conditions, in particular acute myeloid leukemia. My research focuses on fusion oncogenes in leukemia, and I am interested in understanding the epigenetic mechanisms by which oncogenic fusion proteins lead to epigenetic dysregulation in hematopoietic cells.
| University | Degree | Focus | Graduated |
|---|---|---|---|
| Oxford University (Graduate School) | Other Degree | Other | 2007 |
| JOHNS HOPKINS SCHOOL OF MEDICINE | Doctorate | Other | 2015 |
| Johns Hopkins University School of Medicine (Graduate School) | Other Degree | Other | 2015 |
| Institution | Focus | Year |
|---|---|---|
| Residency - Texas Children's Hospital | Other | 2018 |
| Residency - Baylor College of Medicine | Other | 2018 |
| Fellowship - Dana-Farber Cancer Institute | Other | Not Specified |
Accepts New Patients: Yes
Emily Heikamp, MD, PHD, MSC has not yet listed the medications that she commonly prescribes.
Emily Heikamp, MD, PHD, MSC has not yet specified the insurance plans she accepts.